Natriuretic peptides: an update on bioactivity, potential therapeutic use, and implication in cardiovascular diseases.
about
Cardiac-specific overexpression of caveolin-3 attenuates cardiac hypertrophy and increases natriuretic peptide expression and signalingSpotlight on valsartan-sacubitril fixed-dose combination for heart failure: the evidence to dateNeuronal nitric oxide synthase in hypertension - an updatePermeability and contractile responses of collecting lymphatic vessels elicited by atrial and brain natriuretic peptidesPotential prognostic significance of decreased serum levels of TRAIL after acute myocardial infarctionCardiac Natriuretic Peptides, Hypertension and Cardiovascular RiskA contemporary review on the genetic basis of atrial fibrillation.C2238 ANP gene variant promotes increased platelet aggregation through the activation of Nox2 and the reduction of cAMP.Medial temporal lobe functioning and structure in the spontaneously hypertensive rat: comparison with Wistar-Kyoto normotensive and Wistar-Kyoto hypertensive strains.Novel therapy approach in primary stroke prevention: simultaneous inhibition of endothelin converting enzyme and neutral endopeptidase in spontaneously hypertensive, stroke-prone rats improves survival.17β-Estradiol-induced interaction of ERα with NPPA regulates gene expression in cardiomyocytes.Neprilysin Inhibition in Heart Failure with Reduced Ejection Fraction: A Clinical Review.Association of natriuretic peptide polymorphisms with left ventricular dysfunction in southern Han Chinese coronary artery disease patients.Insulin-degrading enzyme modulates the natriuretic peptide-mediated signaling response.Natriuretic hormones, endogenous ouabain, and related sodium transport inhibitors.Impact of obesity on the expression profile of natriuretic peptide system in a rat experimental model.Increased serum N-terminal pro-B-type natriuretic peptide levels in patients with medial arterial calcification and poorly compressible leg arteries.Relation of visceral adiposity to circulating natriuretic peptides in ambulatory individuals.Systolic hypertension: an increasing clinical challenge in AsiaThe C2238/αANP variant is a negative modulator of both viability and function of coronary artery smooth muscle cells.Cardiac natriuretic peptides, obesity, and insulin resistance: evidence from two community-based studies.Prognostic value of circulating amino-terminal pro-C-type natriuretic peptide in critically ill patients.The prevention of acute kidney injury an in-depth narrative review: Part 2: Drugs in the prevention of acute kidney injury.Are there new approaches for diagnosis, therapy guidance and outcome prediction of sepsis?B-type natriuretic peptide is an independent predictor of endothelial function in man.Potential association between frequent nonsynonymous variant of NPPA and cardioembolic strokeCorin is down-regulated and exerts cardioprotective action via activating pro-atrial natriuretic peptide pathway in diabetic cardiomyopathy.Associations Between Genetic Variants of the Natriuretic Peptide System and Blood Pressure Response to Dietary Sodium Intervention: The GenSalt Study.Arterial Remodeling in B-Type Natriuretic Peptide Knock-Out Females.NH2-terminal pro-brain natriuretic peptide and risk of diabetes.B-type natriuretic peptide 8-32, which is produced from mature BNP 1-32 by the metalloprotease meprin A, has reduced bioactivity.Analytical Issues with Natriuretic Peptides - has this been Overly Simplified?CYP2J2 and its metabolites (epoxyeicosatrienoic acids) attenuate cardiac hypertrophy by activating AMPKα2 and enhancing nuclear translocation of Akt1.Serum N-terminal pro-B-type natriuretic peptide levels are associated with functional capacity in patients with peripheral arterial disease.B-type natriuretic peptide as predictor of heart failure in patients with acute ST elevation myocardial infarction, single-vessel disease, and complete revascularization: follow-up study.Natriuretic peptides and cardiovascular damage in the metabolic syndrome: molecular mechanisms and clinical implications.Blood pressures in newborns with twin-twin transfusion syndrome.Molecular mechanisms underlying cardiac antihypertrophic and antifibrotic effects of natriuretic peptides.Natriuretic peptides in cardiovascular diseases: current use and perspectivesAtrial natriuretic peptide gene variants and circulating levels: implications in cardiovascular diseases.
P2860
Q24629099-8A8C5D41-6357-4273-89B0-6C93CAF32291Q28070064-2C538F3F-5C49-446D-B2DD-03602B77E6F9Q28077204-E31B9569-B629-4A8B-AEC0-BBF08FB7B996Q28578075-4F6CF5B4-2EFA-4919-911E-C3B3AAEC9C79Q33409850-33B084CB-D3D6-4591-9F01-C4E75D58E8ABQ33715302-52FB7B20-F575-41F0-8465-BAC7B97BCEF7Q33732880-284145CD-C6CB-4B2A-93F9-538E46B5B7EAQ33812913-560C51F0-BBB0-48B3-BCF4-B05395F14AEAQ33886367-BB2DBF87-C77F-4394-9474-480E1E35C1CDQ33975753-CC521A31-4D7C-465C-97C4-92A0A85F5AE0Q34409624-5087C38A-F6B1-4F2B-81D8-B3D95304DB41Q34495751-32D9FC55-4279-406F-8A30-937592C9F4FEQ34501952-CC388292-5C14-4BA4-AE33-97C5BB2AD291Q34575644-F6A5970F-AF38-47D4-B11C-F575B9C6F466Q34622094-4CEDFFBC-94D4-48A6-ADBF-95848325B735Q34979675-AA19E40E-8B16-472A-AAB7-D3459659179CQ35047848-28498808-190F-4C9B-A72C-ECF7372659CAQ35218885-71D60590-2E78-41E0-A8AA-F31ABDCFA1D9Q35407610-D816C1C8-2EAD-469F-98DC-81539D2B0A72Q35425744-A9493004-ACDC-4C2C-8A5B-1E1730AA5BECQ35432757-D43A3DB0-D05E-4034-A63D-47D57702C1FEQ35566943-253876F5-0DC3-4DFE-B0D5-24BCE7357DE8Q35574190-62F04957-C3EC-4223-BE2C-49407C32A017Q35622257-B37D3A83-A21D-43E0-BBD9-593423428979Q35964757-A273B8EE-8D0A-4E9A-9108-A9EB7770D8EEQ36045171-1FD7E36C-7A1C-4859-A33E-4A184093BCC5Q36135105-1A4FBC58-94FB-464E-97A7-7271C3CCEC25Q36591776-0DB72C3C-775A-4972-80D4-4F0C42468726Q36886130-9C00D37E-9CDC-4EA9-9A16-C3A602B8385AQ37110543-CC621DA1-3C21-4074-ADFE-9F301EB7370CQ37217952-5451D399-D195-42B4-9742-888CDA24F787Q37229313-5E82CCB0-4C24-430C-B162-AE25CB3449C2Q37235552-255571A2-49B3-47DF-B93A-3C756DE75D69Q37373978-071CBC54-DF3B-404E-B109-FE35455B4DB4Q37396223-D7E140A2-71DE-4904-BD31-ACDE54AFA661Q37626852-D70CE69F-63F2-4747-9A6D-4BF0704FBA76Q37831100-28272F37-DE7B-417D-BAC4-89D7ABF5E9FBQ37914058-586A22BA-21A2-4A03-9824-1B9254ED57FEQ38162429-BB823A66-1FE3-4035-9495-8F4C9C4802B3Q38194620-92A51F50-1237-4BBB-A776-6DF9E0349E0D
P2860
Natriuretic peptides: an update on bioactivity, potential therapeutic use, and implication in cardiovascular diseases.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 May 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Natriuretic peptides: an updat ...... on in cardiovascular diseases.
@en
Natriuretic peptides: an updat ...... on in cardiovascular diseases.
@nl
type
label
Natriuretic peptides: an updat ...... on in cardiovascular diseases.
@en
Natriuretic peptides: an updat ...... on in cardiovascular diseases.
@nl
prefLabel
Natriuretic peptides: an updat ...... on in cardiovascular diseases.
@en
Natriuretic peptides: an updat ...... on in cardiovascular diseases.
@nl
P2860
P50
P356
P1476
Natriuretic peptides: an updat ...... ion in cardiovascular diseases
@en
P2093
Valentina Valenti
P2860
P304
P356
10.1038/AJH.2008.174
P577
2008-05-08T00:00:00Z